Neuberger Berman Financial Statements From 2010 to 2025

NEMD Etf  USD 52.23  0.17  0.32%   
Neuberger Berman's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neuberger Berman's valuation are provided below:
Neuberger Berman Emerging does not presently have any fundamental ratios for analysis.
Check Neuberger Berman financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuberger Berman's main balance sheet or income statement drivers, such as , as well as many indicators such as . Neuberger financial statements analysis is a perfect complement when working with Neuberger Berman Valuation or Volatility modules.
This module can also supplement various Neuberger Berman Technical models . Check out the analysis of Neuberger Berman Correlation against competitors.

Neuberger Berman Emerging ETF Price To Earning Analysis

Neuberger Berman's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Neuberger Berman Price To Earning

    
  (6.68) X  
Most of Neuberger Berman's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Neuberger Berman Emerging is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Neuberger Berman Emerging has a Price To Earning of -6.68 times. This is much lower than that of the Healthcare family and significantly lower than that of the Emerging Markets Bond category. The price to earning for all United States etfs is notably higher than that of the company.

Neuberger Berman Emerging Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neuberger Berman's current stock value. Our valuation model uses many indicators to compare Neuberger Berman value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neuberger Berman competition to find correlations between indicators driving Neuberger Berman's intrinsic value. More Info.
Neuberger Berman Emerging is rated number one ETF in price to earning as compared to similar ETFs. It also is rated number one ETF in price to sales as compared to similar ETFs . Comparative valuation analysis is a catch-all technique that is used if you cannot value Neuberger Berman by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

About Neuberger Berman Financial Statements

Neuberger Berman stakeholders use historical fundamental indicators, such as Neuberger Berman's revenue or net income, to determine how well the company is positioned to perform in the future. Although Neuberger Berman investors may analyze each financial statement separately, they are all interrelated. For example, changes in Neuberger Berman's assets and liabilities are reflected in the revenues and expenses on Neuberger Berman's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Neuberger Berman Emerging. Please read more on our technical analysis and fundamental analysis pages.
iNeedMD Holdings, Inc., a medical device development company, researches, develops, markets, and sells medical devices in the United States and internationally. Its product has applications in hospitals, nursing homes and skilled nursing facilities, medical transportation, remote medical assessment, urgent care health clinics, and heart rhythm monitoring. iNeedMD Holdings, Inc. is based in New York, New York. Ineedmd Holdings operates under Medical Appliances Equipment classification in the United States and is traded on OTC Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Neuberger Berman Emerging is a strong investment it is important to analyze Neuberger Berman's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuberger Berman's future performance. For an informed investment choice regarding Neuberger Etf, refer to the following important reports:
Check out the analysis of Neuberger Berman Correlation against competitors.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
The market value of Neuberger Berman Emerging is measured differently than its book value, which is the value of Neuberger that is recorded on the company's balance sheet. Investors also form their own opinion of Neuberger Berman's value that differs from its market value or its book value, called intrinsic value, which is Neuberger Berman's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuberger Berman's market value can be influenced by many factors that don't directly affect Neuberger Berman's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuberger Berman's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuberger Berman is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuberger Berman's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.